Dermisonics, Inc.
Dermisonics, Inc. DMSI Peers
See (DMSI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DMSI | $0.00 | +233.33% | 6.4K | N/A | -$0.44 | N/A |
| BMXXY | $11.42 | -11.81% | 13.5B | 27.85 | $0.41 | +0.80% |
| EBOSY | $47.00 | +12.06% | 2.4B | 25.68 | $1.83 | +2.76% |
| XVIPY | $11.45 | -6.53% | 360.7M | N/A | N/A | N/A |
| EBRCZ | $0.55 | N/A | 204.4M | -4.57 | -$0.12 | N/A |
| TRXDW | $0.15 | -11.76% | 40.1M | N/A | N/A | N/A |
| NVNBW | $1.00 | N/A | 17.5M | -0.51 | -$1.95 | N/A |
| GWPC | $0.00 | N/A | 52K | -0.01 | -$0.01 | N/A |
| OMRX | $0.00 | +89899.32% | 47.9K | -0.04 | -$0.02 | N/A |
| IBXG | $0.00 | +19900.00% | 39.5K | N/A | -$0.07 | N/A |
Stock Comparison
DMSI vs BMXXY Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, BMXXY has a market cap of 13.5B. Regarding current trading prices, DMSI is priced at $0.00, while BMXXY trades at $11.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas BMXXY's P/E ratio is 27.85. In terms of profitability, DMSI's ROE is -0.32%, compared to BMXXY's ROE of +0.10%. Regarding short-term risk, DMSI is more volatile compared to BMXXY. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs EBOSY Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, EBOSY has a market cap of 2.4B. Regarding current trading prices, DMSI is priced at $0.00, while EBOSY trades at $47.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas EBOSY's P/E ratio is 25.68. In terms of profitability, DMSI's ROE is -0.32%, compared to EBOSY's ROE of +0.08%. Regarding short-term risk, DMSI is more volatile compared to EBOSY. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs XVIPY Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, XVIPY has a market cap of 360.7M. Regarding current trading prices, DMSI is priced at $0.00, while XVIPY trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas XVIPY's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to XVIPY's ROE of +0.10%. Regarding short-term risk, DMSI is more volatile compared to XVIPY. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs EBRCZ Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, EBRCZ has a market cap of 204.4M. Regarding current trading prices, DMSI is priced at $0.00, while EBRCZ trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas EBRCZ's P/E ratio is -4.57. In terms of profitability, DMSI's ROE is -0.32%, compared to EBRCZ's ROE of -2.89%. Regarding short-term risk, DMSI is more volatile compared to EBRCZ. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs TRXDW Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, TRXDW has a market cap of 40.1M. Regarding current trading prices, DMSI is priced at $0.00, while TRXDW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas TRXDW's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to TRXDW's ROE of -5.59%. Regarding short-term risk, DMSI is more volatile compared to TRXDW. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs NVNBW Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, NVNBW has a market cap of 17.5M. Regarding current trading prices, DMSI is priced at $0.00, while NVNBW trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas NVNBW's P/E ratio is -0.51. In terms of profitability, DMSI's ROE is -0.32%, compared to NVNBW's ROE of -0.51%. Regarding short-term risk, DMSI is more volatile compared to NVNBW. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs GWPC Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, GWPC has a market cap of 52K. Regarding current trading prices, DMSI is priced at $0.00, while GWPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas GWPC's P/E ratio is -0.01. In terms of profitability, DMSI's ROE is -0.32%, compared to GWPC's ROE of N/A. Regarding short-term risk, DMSI is more volatile compared to GWPC. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs OMRX Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, OMRX has a market cap of 47.9K. Regarding current trading prices, DMSI is priced at $0.00, while OMRX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas OMRX's P/E ratio is -0.04. In terms of profitability, DMSI's ROE is -0.32%, compared to OMRX's ROE of -0.15%. Regarding short-term risk, DMSI is less volatile compared to OMRX. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs IBXG Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, IBXG has a market cap of 39.5K. Regarding current trading prices, DMSI is priced at $0.00, while IBXG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas IBXG's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to IBXG's ROE of N/A. Regarding short-term risk, DMSI is less volatile compared to IBXG. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs SXHHF Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, SXHHF has a market cap of 38.1K. Regarding current trading prices, DMSI is priced at $0.00, while SXHHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas SXHHF's P/E ratio is -0.01. In terms of profitability, DMSI's ROE is -0.32%, compared to SXHHF's ROE of +1.13%. Regarding short-term risk, DMSI is less volatile compared to SXHHF. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs BMGP Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, BMGP has a market cap of 12.7K. Regarding current trading prices, DMSI is priced at $0.00, while BMGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas BMGP's P/E ratio is -0.01. In terms of profitability, DMSI's ROE is -0.32%, compared to BMGP's ROE of -0.50%. Regarding short-term risk, DMSI is less volatile compared to BMGP. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs KKUR Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, KKUR has a market cap of 8.2K. Regarding current trading prices, DMSI is priced at $0.00, while KKUR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas KKUR's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to KKUR's ROE of N/A. Regarding short-term risk, DMSI is more volatile compared to KKUR. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs IMRSQ Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, IMRSQ has a market cap of 6.3K. Regarding current trading prices, DMSI is priced at $0.00, while IMRSQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas IMRSQ's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to IMRSQ's ROE of -1.30%. Regarding short-term risk, DMSI is less volatile compared to IMRSQ. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs SCIE Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, SCIE has a market cap of 4.9K. Regarding current trading prices, DMSI is priced at $0.00, while SCIE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas SCIE's P/E ratio is -0.01. In terms of profitability, DMSI's ROE is -0.32%, compared to SCIE's ROE of +0.00%. Regarding short-term risk, DMSI is more volatile compared to SCIE. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs STBV Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, STBV has a market cap of 4.7K. Regarding current trading prices, DMSI is priced at $0.00, while STBV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas STBV's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to STBV's ROE of -1.13%. Regarding short-term risk, DMSI is more volatile compared to STBV. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs DGCRF Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, DGCRF has a market cap of 4.3K. Regarding current trading prices, DMSI is priced at $0.00, while DGCRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas DGCRF's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to DGCRF's ROE of -1.11%. Regarding short-term risk, DMSI is less volatile compared to DGCRF. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs AAXT Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, AAXT has a market cap of 1.6K. Regarding current trading prices, DMSI is priced at $0.00, while AAXT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas AAXT's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to AAXT's ROE of +0.54%. Regarding short-term risk, DMSI is more volatile compared to AAXT. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.
DMSI vs XCRP Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, XCRP has a market cap of 1.5K. Regarding current trading prices, DMSI is priced at $0.00, while XCRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas XCRP's P/E ratio is -0.00. In terms of profitability, DMSI's ROE is -0.32%, compared to XCRP's ROE of -3.49%. Regarding short-term risk, DMSI is less volatile compared to XCRP. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs OMDD Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, OMDD has a market cap of 310. Regarding current trading prices, DMSI is priced at $0.00, while OMDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas OMDD's P/E ratio is N/A. In terms of profitability, DMSI's ROE is -0.32%, compared to OMDD's ROE of N/A. Regarding short-term risk, DMSI is less volatile compared to OMDD. This indicates potentially lower risk in terms of short-term price fluctuations for DMSI.
DMSI vs QMED Comparison
DMSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMSI stands at 6.4K. In comparison, QMED has a market cap of 17. Regarding current trading prices, DMSI is priced at $0.00, while QMED trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMSI currently has a P/E ratio of N/A, whereas QMED's P/E ratio is -0.00. In terms of profitability, DMSI's ROE is -0.32%, compared to QMED's ROE of N/A. Regarding short-term risk, DMSI is more volatile compared to QMED. This indicates potentially higher risk in terms of short-term price fluctuations for DMSI.